vs

Side-by-side financial comparison of Arcellx, Inc. (ACLX) and CHICAGO RIVET & MACHINE CO (CVR). Click either name above to swap in a different company.

Arcellx, Inc. is the larger business by last-quarter revenue ($8.1M vs $6.0M, roughly 1.4× CHICAGO RIVET & MACHINE CO). CHICAGO RIVET & MACHINE CO runs the higher net margin — -19.3% vs -766.0%, a 746.7% gap on every dollar of revenue. On growth, CHICAGO RIVET & MACHINE CO posted the faster year-over-year revenue change (45.9% vs -79.3%). CHICAGO RIVET & MACHINE CO produced more free cash flow last quarter ($24.3K vs $-63.9M). Over the past eight quarters, CHICAGO RIVET & MACHINE CO's revenue compounded faster (-12.7% CAGR vs -24.6%).

Arcellx, Inc. is a clinical-stage biotechnology company that develops innovative chimeric antigen receptor T (CAR-T) cell therapies for treating hard-to-treat cancers including hematologic malignancies and solid tumors. Its core pipeline targets unmet oncology medical needs, serving global patient populations and partnering with life sciences stakeholders.

Chicago Pneumatic, also known as "CP", is an industrial manufacturer providing power tools, air compressors, generators, light towers and hydraulic equipment. Products are sold in more than 150 countries through a worldwide distribution network. CP is active on markets such as tools for industrial production, vehicle service, maintenance repair operation for mining, construction, infrastructure equipment.

ACLX vs CVR — Head-to-Head

Bigger by revenue
ACLX
ACLX
1.4× larger
ACLX
$8.1M
$6.0M
CVR
Growing faster (revenue YoY)
CVR
CVR
+125.2% gap
CVR
45.9%
-79.3%
ACLX
Higher net margin
CVR
CVR
746.7% more per $
CVR
-19.3%
-766.0%
ACLX
More free cash flow
CVR
CVR
$63.9M more FCF
CVR
$24.3K
$-63.9M
ACLX
Faster 2-yr revenue CAGR
CVR
CVR
Annualised
CVR
-12.7%
-24.6%
ACLX

Income Statement — Q1 FY2025 vs Q4 FY2025

Metric
ACLX
ACLX
CVR
CVR
Revenue
$8.1M
$6.0M
Net Profit
$-62.3M
$-1.2M
Gross Margin
2.7%
Operating Margin
-847.6%
-15.3%
Net Margin
-766.0%
-19.3%
Revenue YoY
-79.3%
45.9%
Net Profit YoY
-765.1%
68.0%
EPS (diluted)
$-1.13

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
ACLX
ACLX
CVR
CVR
Q4 25
$6.0M
Q3 25
$7.4M
Q2 25
$7.3M
Q1 25
$8.1M
$7.2M
Q4 24
$15.3M
$4.1M
Q3 24
$26.0M
$7.0M
Q2 24
$27.4M
$8.1M
Q1 24
$39.3M
$7.9M
Net Profit
ACLX
ACLX
CVR
CVR
Q4 25
$-1.2M
Q3 25
$67.6K
Q2 25
$-395.0K
Q1 25
$-62.3M
$401.0K
Q4 24
$-47.1M
$-3.6M
Q3 24
$-25.9M
$-1.4M
Q2 24
$-27.2M
$142.1K
Q1 24
$-7.2M
$-698.0K
Gross Margin
ACLX
ACLX
CVR
CVR
Q4 25
2.7%
Q3 25
18.1%
Q2 25
13.4%
Q1 25
22.9%
Q4 24
-43.7%
Q3 24
10.0%
Q2 24
17.6%
Q1 24
9.5%
Operating Margin
ACLX
ACLX
CVR
CVR
Q4 25
-15.3%
Q3 25
0.9%
Q2 25
-5.7%
Q1 25
-847.6%
1.0%
Q4 24
-348.2%
-86.4%
Q3 24
-129.1%
-11.8%
Q2 24
-127.8%
1.3%
Q1 24
-40.3%
-11.5%
Net Margin
ACLX
ACLX
CVR
CVR
Q4 25
-19.3%
Q3 25
0.9%
Q2 25
-5.4%
Q1 25
-766.0%
5.5%
Q4 24
-308.4%
-88.0%
Q3 24
-99.4%
-20.8%
Q2 24
-99.3%
1.8%
Q1 24
-18.3%
-8.9%
EPS (diluted)
ACLX
ACLX
CVR
CVR
Q4 25
Q3 25
Q2 25
Q1 25
$-1.13
Q4 24
$-0.87
Q3 24
$-0.48
Q2 24
$-0.51
Q1 24
$-0.14

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
ACLX
ACLX
CVR
CVR
Cash + ST InvestmentsLiquidity on hand
$543.3M
$1.7M
Total DebtLower is stronger
Stockholders' EquityBook value
$416.9M
$18.8M
Total Assets
$648.1M
$23.3M
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
ACLX
ACLX
CVR
CVR
Q4 25
$1.7M
Q3 25
$1.7M
Q2 25
$1.2M
Q1 25
$543.3M
$765.6K
Q4 24
$587.4M
$2.2M
Q3 24
$574.3M
$2.2M
Q2 24
$516.7M
$2.6M
Q1 24
$573.9M
$2.7M
Total Debt
ACLX
ACLX
CVR
CVR
Q4 25
Q3 25
Q2 25
Q1 25
Q4 24
$0
Q3 24
Q2 24
Q1 24
Stockholders' Equity
ACLX
ACLX
CVR
CVR
Q4 25
$18.8M
Q3 25
$20.0M
Q2 25
$20.0M
Q1 25
$416.9M
$20.4M
Q4 24
$454.8M
$20.0M
Q3 24
$483.0M
$23.7M
Q2 24
$487.2M
$25.2M
Q1 24
$496.6M
$25.2M
Total Assets
ACLX
ACLX
CVR
CVR
Q4 25
$23.3M
Q3 25
$24.0M
Q2 25
$23.6M
Q1 25
$648.1M
$24.1M
Q4 24
$711.3M
$23.4M
Q3 24
$764.9M
$26.4M
Q2 24
$734.3M
$27.3M
Q1 24
$779.7M
$27.8M
Debt / Equity
ACLX
ACLX
CVR
CVR
Q4 25
Q3 25
Q2 25
Q1 25
Q4 24
0.00×
Q3 24
Q2 24
Q1 24

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
ACLX
ACLX
CVR
CVR
Operating Cash FlowLast quarter
$-63.1M
$116.4K
Free Cash FlowOCF − Capex
$-63.9M
$24.3K
FCF MarginFCF / Revenue
-786.4%
0.4%
Capex IntensityCapex / Revenue
9.6%
1.5%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters
$-122.5M
$-1.6M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
ACLX
ACLX
CVR
CVR
Q4 25
$116.4K
Q3 25
$638.0K
Q2 25
$28.2K
Q1 25
$-63.1M
$-2.0M
Q4 24
$-46.0M
$-60.1K
Q3 24
$30.7M
$-58.2K
Q2 24
$-36.2M
$363.5K
Q1 24
$-31.9M
$-398.8K
Free Cash Flow
ACLX
ACLX
CVR
CVR
Q4 25
$24.3K
Q3 25
$492.1K
Q2 25
$-22.8K
Q1 25
$-63.9M
$-2.1M
Q4 24
$-47.5M
$-118.1K
Q3 24
$28.4M
$-368.9K
Q2 24
$-39.5M
$58.0K
Q1 24
$-38.3M
$-491.8K
FCF Margin
ACLX
ACLX
CVR
CVR
Q4 25
0.4%
Q3 25
6.7%
Q2 25
-0.3%
Q1 25
-786.4%
-28.3%
Q4 24
-311.3%
-2.9%
Q3 24
109.2%
-5.3%
Q2 24
-144.1%
0.7%
Q1 24
-97.7%
-6.3%
Capex Intensity
ACLX
ACLX
CVR
CVR
Q4 25
1.5%
Q3 25
2.0%
Q2 25
0.7%
Q1 25
9.6%
0.6%
Q4 24
9.8%
1.4%
Q3 24
8.8%
4.5%
Q2 24
11.7%
3.8%
Q1 24
16.4%
1.2%
Cash Conversion
ACLX
ACLX
CVR
CVR
Q4 25
Q3 25
9.44×
Q2 25
Q1 25
-5.01×
Q4 24
Q3 24
Q2 24
2.56×
Q1 24

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

ACLX
ACLX

Segment breakdown not available.

CVR
CVR

Fastener$5.1M85%
Other$890.7K15%

Related Comparisons